Neuroleptic Malignant Syndrome
National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Neuroleptic Malignant Syndrome is not the name you expected.
Neuroleptic malignant syndrome is a rare but potentially life-threatening reaction to the use of almost any of a group of antipsychotic drugs or major tranquilizers (neuroleptics). These drugs are commonly prescribed for the treatment of schizophrenia and other neurological, mental, or emotional disorders. Several of the more commonly prescribed neuroleptics include thioridazine, haloperidol, chlorpromazine, fluphenazine and perphenazine.
The syndrome is characterized by high fever, stiffness of the muscles, altered mental status (paranoid behavior), and autonomic dysfunction. Autonomic dysfunction alludes to defective operations of the components of the involuntary (autonomic) nervous system, leading to wide swings of blood pressure, excessive sweating and excessive secretion of saliva.
A genetic basis for the disorder is suspected but not proven. It does appear to be clear that a defect in the receptors to dopamine (dopamine D2 receptor antagonism) is an important contributor to the cause of neuroleptic malignant syndrome.
Malignant Hyperthermia Association of the United States
- 1 North Main St
- PO Box 1069
- Sherburne, NY 13460
- Tel: (607)674-7901
- Fax: (607)674-7910
- Email: email@example.com
- Website: http://www.mhaus.org
MedicAlert Foundation International
- 2323 Colorado Avenue
- Turlock, CA 95382
- Tel: (209)669-2401
- Fax: (209)669-2456
- Tel: (888)633-4298
- Email: Inquiries@medicalert.org
- Website: http://www.medicalert.org
Mental Health America
- 2000 N. Beauregard Street, 6th Floor
- Alexandria, VA 22314-2971
- Tel: (703)684-7722
- Fax: (703)684-5968
- Tel: (800)969-6642
- Email: firstname.lastname@example.org
- Website: http://www.mentalhealthamerica.net/
NIH/National Institute of Mental Health
- Health Science Writing, Press and Dissemination Branch
- 6001 Executive Boulevard
- Bethesda, MD 20892-9663
- Tel: (301)443-4513
- Fax: (301)443-4279
- Tel: (866)615-6464
- Email: email@example.com
- Website: http://www.nimh.nih.gov/index.shtml
National Alliance on Mental Illness
- 3803 N. Fairfax Drive
- Suite 100
- Arlington, VA 22203-
- Tel: (703)524-7600
- Fax: (703)524-9094
- Tel: (800)999-6264
- Email: firstname.lastname@example.org
- Website: http://www.nami.org
National Mental Health Consumers' Self-Help Clearinghouse
- 1211 Chestnut Street
- Suite 1207
- Philadelphia, PA 19107-6312
- Tel: (215)751-1810
- Fax: (215)636-6312
- Tel: (800)553-4539
- Email: email@example.com
- Website: http://www.mhselfhelp.org
North American Malignant Hyperthermia Registry
- Penn State University
- Dept. of Anesthesiology
- Hershey, PA 17033-0850
- Tel: (412)692-6390
- Fax: (412)692-8658
- Tel: (888)274-7899
- Email: firstname.lastname@example.org
- Website: http://www.mhreg.org
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders (NORD). For a full-text version of this report, go to www.rarediseases.org and click on Rare Disease Database under "Rare Disease Information".
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report.
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
Last Updated: 5/1/2008
Copyright 2004 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.